Hidalgo C, Petrucci D A, Vergara C
J Biol Chem. 1982 Jan 10;257(1):208-16.
Limited labeling of amino groups with fluorescamine in fragmented sarcoplasmic reticulum vesicles inhibits Ca2+-ATPase activity and Ca2+ transport. Under the labeling conditions used, 80% of the label reacts with phosphatidylethanolamine and 20% with the Ca2+-ATPase polypeptide. This degree of labeling does not result in vesicular disruption or in loss of vesicular proteins and does not increase the membrane permeability to Ca2+. Fluorescamine labeling of a purified Ca2+-ATPase devoid of aminophospholipids also inhibits Ca2+-ATPase activity, suggesting that labeling of lysine residues of the enzyme polypeptide is responsible for the inhibition of Ca2+-ATPase activity in sarcoplasmic reticulum. Fluorescamine labeling interferes with phosphoenzyme formation and decomposition in both the native vesicles and the purified enzyme; addition of ATP during labeling, and with less effectiveness ADP or AMP, protects both partial reaction steps. Addition of a nonhydrolyzable ATP analog protects phosphoenzyme formation but not decomposition. The inhibition of Ca2+ transport but not of Ca2+-ATPase occurs in sarcoplasmic reticulum vesicles labeled in the presence of ATP, indicating that the transport reaction is uncoupled from the Ca2+-ATPase reaction. The inhibition of Ca2+ transport but not of Ca2+-ATPase activity is also found in sarcoplasmic reticulum vesicles in which only phosphatidylethanolamine has reacted with fluorescamine. Furthermore, the extent of labeling of phosphatidylethanolamine is correlated with the inhibition of Ca2+ transport rates. The inhibition of Ca2+ transport is a reflection of the inhibition of Ca2+ translocation and is not due to an increase in Ca2+ efflux. We propose that labeling of phosphatidylethanolamine perturbs the lipid environment around the enzyme, producing a specific defect in the Ca2+ translocation reaction.
在肌浆网囊泡片段中,用荧光胺对氨基进行有限标记会抑制Ca2 + -ATP酶活性和Ca2 +转运。在所使用的标记条件下,80%的标记物与磷脂酰乙醇胺反应,20%与Ca2 + -ATP酶多肽反应。这种标记程度不会导致囊泡破裂或囊泡蛋白丢失,也不会增加膜对Ca2 +的通透性。对不含氨基磷脂的纯化Ca2 + -ATP酶进行荧光胺标记也会抑制Ca2 + -ATP酶活性,这表明酶多肽赖氨酸残基的标记是肌浆网中Ca2 + -ATP酶活性受到抑制的原因。荧光胺标记会干扰天然囊泡和纯化酶中磷酸酶的形成和分解;在标记过程中添加ATP,以及效果稍差的ADP或AMP,可保护这两个部分反应步骤。添加不可水解的ATP类似物可保护磷酸酶的形成,但不能保护其分解。在ATP存在下标记的肌浆网囊泡中,Ca2 +转运受到抑制,但Ca2 + -ATP酶不受抑制,这表明转运反应与Ca2 + -ATP酶反应解偶联。在仅磷脂酰乙醇胺与荧光胺反应的肌浆网囊泡中,也发现Ca2 +转运受到抑制,但Ca2 + -ATP酶活性不受抑制。此外,磷脂酰乙醇胺的标记程度与Ca2 +转运速率的抑制相关。Ca2 +转运的抑制反映了Ca2 +转运的抑制,而不是由于Ca2 +外流增加。我们认为,磷脂酰乙醇胺的标记会扰乱酶周围的脂质环境,在Ca2 +转运反应中产生特定缺陷。